文献速递心脑血管急症重症综合管理与镇静镇痛儿科与产科急症

儿童重型创伤性脑损伤高渗盐水与甘露醇治疗前后颅内压测量的比较

Comparison of Intracranial Pressure Measurements Before and After Hypertonic Saline or Mannitol Treatment in Children With Severe Traumatic Brain Injury.
PubMed 文献 · JAMA Netw Open · 2022-03-01
一句话结论儿童重型颅脑损伤中,高渗盐水团注与颅内压降低和脑灌注压升高相关,甘露醇仅与脑灌注压升高相关;校正混杂后两者对颅内压和脑灌注压均无显著关联,但颅内压危象时高渗盐水表现优于甘露醇。

该比较效果研究纳入44个临床中心、8个国家的518例接受高渗盐水或甘露醇团注的儿童重型创伤性脑损伤患者(平均年龄7.6岁,平均格拉斯哥昏迷评分5.2分)。高渗盐水团注与颅内压降低(平均1.03 mm Hg,P<.001)和脑灌注压升高(平均1.25 mm Hg,P<.001)相关,甘露醇仅与脑灌注压升高相关(平均1.20 mm Hg,P=.009)。主要结局中,高渗盐水与甘露醇相比颅内压降低更多(未校正β=-0.85,95%CI -1.53至-0.19),但校正后无显著关联(校正β=-0.53,95%CI -1.32至0.25,P=.18);脑灌注压无差异。当颅内压>20、>25、>30 mm Hg时,高渗盐水颅内压降低均优于甘露醇(未校正β分别为-2.51、-3.88、-4.07,均P<.001),校正后颅内压>25 mm Hg时仍显著。结论提示颅内压危象时高渗盐水可能表现更优。

要点

  • 儿童重型颅脑损伤(平均GCS 5.2分)团注高渗盐水与颅内压降低(平均1.03 mm Hg,P<.001)和脑灌注压升高(平均1.25 mm Hg,P<.001)相关。
  • 甘露醇团注仅与脑灌注压升高相关(平均1.20 mm Hg,P=.009),未观察到与颅内压降低相关。
  • 校正混杂因素后,高渗盐水与甘露醇对颅内压(校正β=-0.53,95%CI -1.32至0.25,P=.18)和脑灌注压均无显著关联。
  • 颅内压>20 mm Hg时高渗盐水颅内压降低优于甘露醇(未校正β=-2.51,95%CI -3.86至-1.15,P<.001)。
  • 颅内压>25 mm Hg时高渗盐水颅内压降低优于甘露醇(未校正β=-3.88,95%CI -5.69至-2.06,P<.001),校正后仍显著。

适用人群与场景

  • 接受颅内压导向治疗的儿童重型创伤性脑损伤患者,来自44个临床中心、8个国家,共518例纳入分析。
  • 平均(SD)年龄7.6(5.4)岁;336例(64.9%)男性;274例(52.9%)白人;平均(SD)格拉斯哥昏迷评分5.2(1.8)分。
  • 1018例儿童被筛查,18例被排除;787例在颅内压导向治疗阶段接受某种形式的高渗治疗,其中521例接受团注;3例因同一小时内仅接受高渗盐水和甘露醇两者团注而被排除,最终518例分析。

处置流程与药物剂量

  • 高渗盐水团注与甘露醇团注作为儿童重型创伤性脑损伤的高渗治疗用于颅内压导向治疗阶段;原文未报告具体剂量、浓度、给药频次或疗程。

研究设计与关键结果

  • 比较效果研究:2014年2月1日至2017年9月31日开展,伤后随访1周,最终分析于2021年7月20日进行;纳入518例儿童(44个临床中心、8个国家)。
  • 高渗盐水团注与颅内压降低相关(平均[SD] 1.03[6.77] mm Hg;P<.001),并与脑灌注压升高相关(平均[SD] 1.25[12.47] mm Hg;P<.001)。
  • 甘露醇团注与脑灌注压升高相关(平均[SD] 1.20[11.43] mm Hg;P=.009)。
  • 主要结局:高渗盐水与甘露醇相比颅内压降低更多(未校正β=-0.85;95%CI -1.53至-0.19),校正后无显著关联(校正β=-0.53;95%CI -1.32至0.25;P=.18);脑灌注压未见差异。
  • 颅内压>20 mm Hg时,高渗盐水颅内压降低优于甘露醇(未校正β=-2.51;95%CI -3.86至-1.15;P<.001)。
  • 颅内压>25 mm Hg时,高渗盐水颅内压降低优于甘露醇(未校正β=-3.88;95%CI -5.69至-2.06;P<.001),校正分析中仍显著。
  • 颅内压>30 mm Hg时,高渗盐水颅内压降低优于甘露醇(未校正β=-4.07;95%CI -6.35至-1.79;P<.001)。

证据类型、等级与局限

  • 证据类型:比较效果研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在儿童重型创伤性脑损伤颅内压危象时,高渗盐水团注可能与比甘露醇更大幅度的颅内压降低相关;校正混杂后两者对颅内压和脑灌注压均无显著关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Hyperosmolar agents are cornerstone therapies for pediatric severe traumatic brain injury. Guideline recommendations for 3% hypertonic saline (HTS) are based on limited numbers of patients, and no study to date has supported a recommendation for mannitol.

OBJECTIVES: To characterize current use of hyperosmolar agents in pediatric severe traumatic brain injury and assess whether HTS or mannitol is associated with greater decreases in intracranial pressure (ICP) and/or increases in cerebral perfusion pressure (CPP).

DESIGN, SETTING, AND PARTICIPANTS: In this comparative effectiveness research study, 1018 children were screened and 18 were excluded; 787 children received some form of hyperosmolar therapy during the ICP-directed phase of care, with 521 receiving a bolus. Three of these children were excluded because they had received only bolus administration of both HTS and mannitol in the same hour, leaving 518 children (at 44 clinical sites in 8 countries) for analysis. The study was conducted from February 1, 2014, to September 31, 2017, with follow-up for 1 week after injury. Final analysis was performed July 20, 2021.

INTERVENTIONS: Boluses of HTS and mannitol were administered.

MAIN OUTCOMES AND MEASURES: Data on ICP and CPP were collected before and after medication administration. Statistical methods included linear mixed models and corrections for potential confounding variables to compare the 2 treatments.

RESULTS: A total of 518 children (mean [SD] age, 7.6 [5.4] years; 336 [64.9%] male; 274 [52.9%] White) were included. Participants' mean (SD) Glasgow Coma Scale score was 5.2 (1.8). Bolus HTS was observed to decrease ICP and increase CPP (mean [SD] ICP, 1.03 [6.77] mm Hg; P < .001; mean [SD] CPP, 1.25 [12.47] mm Hg; P < .001), whereas mannitol was observed to increase CPP (mean [SD] CPP, 1.20 [11.43] mm Hg; P = .009). In the primary outcome, HTS was associated with a greater reduction in ICP compared with mannitol (unadjusted β, -0.85; 95% CI, -1.53 to -0.19), but no association was seen after adjustments (adjusted β, -0.53; 95% CI, -1.32 to 0.25; P = .18). No differences in CPP were observed. When ICP was greater than 20 mm Hg, greater than 25 mm Hg, or greater than 30 mm Hg, HTS outperformed mannitol for each threshold in observed ICP reduction (>20 mm Hg: unadjusted β, -2.51; 95% CI, -3.86 to -1.15, P < .001; >25 mm Hg: unadjusted β, -3.88; 95% CI, -5.69 to -2.06, P < .001; >30 mm Hg: unadjusted β, -4.07; 95% CI, -6.35 to -1.79, P < .001), with results remaining significant for ICP greater than 25 mm Hg in adjusted analysis.

CONCLUSIONS AND RELEVANCE: In this comparative effectiveness research study, bolus HTS was associated with lower ICP and higher CPP, whereas mannitol was associated only with higher CPP. After adjustment for confounders, both therapies showed no association with ICP and CPP. During ICP crises, HTS was associated with better performance than mannitol.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Kochanek PM, Adelson PD, Rosario BL, et al. Comparison of Intracranial Pressure Measurements Before and After Hypertonic Saline or Mannitol Treatment in Children With Severe Traumatic Brain Injury. JAMA Netw Open. 2022. PMID: 35267036. doi:10.1001/jamanetworkopen.2022.0891

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。